Racial Disparity in Myeloablative Hematopoietic Cell Transplantation Outcomes in Patients with Hematological Malignancies Older Than 45 Years
Our study confirms that South Asians aged ≥ 45 years have worse survival after MAC-HCT. Supportive care is unable to overcome the differences in the outcomes.
Authors
- Deepesh Lad (ORCID: https://orcid.org/0000-0003-3754-7774)
- Cynthia L. Toze
- Shanee Chung (ORCID: https://orcid.org/0000-0002-0375-4858)
- Jeff White (ORCID: https://orcid.org/0000-0002-0277-5921)
- Thomas J. Nevill (ORCID: https://orcid.org/0000-0002-3124-541X)
- Claudie Roy (ORCID: https://orcid.org/0000-0002-9218-5801)
- Satarupa Mohapatra
- Sujaatha Narayanan
- Yasser R. Abou Mourad
- Katie Lacaria
- Ryan J. Stubbins (ORCID: https://orcid.org/0000-0002-4718-5212)
- Hannah Cherniawsky (ORCID: https://orcid.org/0000-0001-6742-8499)
- Joanna E. MacLean (ORCID: https://orcid.org/0000-0001-7994-9910)
- Florian Kuchenbauer (ORCID: https://orcid.org/0000-0002-9820-3409)
- A. MAUREEN ROUHI (ORCID: https://orcid.org/0000-0002-6450-027X)
- Kevin Song (ORCID: https://orcid.org/0000-0003-0786-7961)
- Stephen H. Nantel
- Judith Anula Rodrigo
- David Sanford
- Donna L. Forrest
- Gagan Kaila
Institutions
- University of British Columbia (CA)
- Leukemia & Lymphoma Society of Canada (CA)
Publication Details
- Journal
- BLOOD CELL THERAPY / The official journal of APBMT
- Published
- 2025-01-01
- DOI
- https://doi.org/10.31547/bct-2025-001
- Primary Topic
- Hematopoietic Stem Cell Transplantation
- Type
- article
- Field-Weighted Citation Impact
- 0.00